SCHEMBL375127

SCHEMBL375127

FC(F)(F)c1cccc(CNC2CCSCC2)c1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 2/20 0.59
PRMT6 Q96LA8 2/20 0.59
TEAD1 P28347 3/20 0.53
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ATM Q13315 1/20 0.47
BCHE P06276 1/20 0.46
ACHE P22303 1/20 0.46
BACE1 P56817 1/20 0.46
MLYCD O95822 1/20 0.45
SMYD3 Q9H7B4 1/20 0.44
DPP7 Q9UHL4 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43
POLB P06746 1/20 0.43
HTT P42858 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAOB P27338 1/20 0.42
IDO1 P14902 1/20 0.42
CCR2 P41597 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2470940 0.90 CARM1 (0.66) CARM1PRMT6TEAD1MEN1KMT2A
SCHEMBL29456933 0.90 CARM1 (0.66) CARM1PRMT6TEAD1MEN1KMT2A
Hydrochloric Acid SCHEMBL30117154 0.88 CARM1 (0.64) CARM1PRMT6TEAD1MEN1KMT2A
SCHEMBL23200173 0.87 CARM1 (0.63) CARM1PRMT6TEAD1MEN1KMT2A
SCHEMBL4244332 0.87 CARM1 (0.63) CARM1PRMT6TEAD1MEN1KMT2A
SCHEMBL375071 0.83 CARM1 (0.59) CARM1PRMT6TEAD1MEN1KMT2A
SCHEMBL3816081 0.83 CARM1 (0.59) CARM1PRMT6TEAD1MEN1KMT2A
SCHEMBL6858410 0.83 CARM1 (0.62) CARM1PRMT6TEAD1MEN1KMT2A
Formic Acid SCHEMBL5076807 0.82 TEAD1 (0.61) CARM1PRMT6TEAD1MEN1KMT2A
Methylene Chloride SCHEMBL27890329 0.80 CARM1 (0.56) CARM1PRMT6TEAD1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623898-B2 Glycine transporter inhibiting substances TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-01-07 US disclosed
EP-2409976-A1 GLYCINE TRANSPORTER INHIBITOR Taisho Pharmaceutical Co., Ltd. (JP) 2012-01-25 EP disclosed
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES SLC18A2, SLC1A2, SLC6A1 CARM1 2663/4885PRMT6 2112/4885TEAD1 1950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.